Xeris Pharmaceuticals Completes $41M Financing to Advance Glucagon Formulations
News
Texas-based Xeris Pharmaceuticals, which develops and commercializes novel formulations of injectable drugs for multiple indications including diabetes, recently announced the closing of a Series C financing worth $41 million. The capital will go ... Read more